Left side headache in adult
unilateral headache differential diagnosis adult
| Feature | Cluster Headache | Paroxysmal Hemicrania | SUNCT/SUNA |
|---|---|---|---|
| Gender | M > F | F = M | F ~ M |
| Pain quality | Stabbing, boring | Throbbing, boring | Burning, stabbing |
| Severity | Excruciating | Excruciating | Severe-excruciating |
| Site | Orbit, temple | Orbit, temple | Periorbital |
| Duration | 15-180 min | 2-30 min | 5-240 seconds |
| Frequency | 1 every other day to 8/day | 1-20/day | 3-200/day |
| Autonomic features | Yes (lacrimation, nasal congestion, conjunctival injection) | Yes | Yes (prominent) |
| Alcohol trigger | Yes | No | No |
| Cutaneous triggers | No | No | Yes |
| Key treatment | Sumatriptan injection/nasal spray; O2; verapamil (preventive) | Indomethacin (diagnostic & therapeutic) | Lidocaine IV (abortive); lamotrigine (preventive) |
| Red Flag Feature | Potential Cause |
|---|---|
| Sudden thunderclap onset ("worst headache of life") | Subarachnoid hemorrhage (SAH) |
| Wakes from sleep / early morning headache | Elevated intracranial pressure (ICP) |
| Progressive worsening in frequency/severity | Intracranial mass lesion |
| Worse with recumbency or Valsalva | Elevated ICP, Chiari malformation |
| Fever + headache | Meningitis, encephalitis |
| Neurologic symptoms (focal weakness, vision change, gait change) | Stroke, mass, hemorrhage |
| Age >50 with new headache + scalp tenderness + jaw claudication | Giant cell arteritis (temporal arteritis) |
| Unilateral + neck pain + recent trauma | Carotid artery dissection |
| History of malignancy | Brain metastases |
| Pregnancy | Cerebral venous sinus thrombosis, preeclampsia |
| Disorder | Acute Treatment | Prevention |
|---|---|---|
| Migraine | NSAIDs, triptans, antiemetics | Topiramate, propranolol, amitriptyline, CGRP antagonists |
| Cluster headache | Sumatriptan SC/nasal, O2 100% | Verapamil, galcanezumab, lithium |
| Paroxysmal hemicrania | Indomethacin | Indomethacin |
| Tension-type | NSAIDs, acetaminophen | Amitriptyline |
| Giant cell arteritis | High-dose prednisone (1 mg/kg) | Taper per clinical response |
Clinical Pearl: The side of unilateral headache can change between attacks in migraine (strictly always-same-side raises concern for a structural lesion). In cluster headache and paroxysmal hemicrania, the pain is always on the same side within a cluster period.
Cord around the neck in fetus and cefalic pregention
nuchal cord management delivery outcome

| FHR Pattern | Association | Management |
|---|---|---|
| Variable decelerations (intermittent) | Cord compression (nuchal cord) | Usually benign; observe |
| Persistent repetitive variable decelerations | Ongoing cord compression, possible hypoxia | Change maternal position (left lateral, knee-chest), IV fluids, O2, consider amnioinfusion |
| Late decelerations | Uteroplacental insufficiency | Urgent intervention |
| Prolonged bradycardia | Severe cord compression or abruption | Emergency delivery |
| Complication | Mechanism |
|---|---|
| Fetal asphyxia / hypoxia | Cord compression reduces O2 delivery |
| Metabolic acidosis | Prolonged hypoxia |
| Low Apgar scores | Neonatal depression |
| Hypoxic-ischemic encephalopathy (HIE) | Severe/prolonged asphyxia |
| Neonatal death (rare) | Extreme cord compromise |
Aspirate risk in newborn
meconium aspiration syndrome newborn management
| Type | Substance Aspirated | Timing |
|---|---|---|
| Meconium Aspiration Syndrome (MAS) | Meconium (fetal stool) | Antenatal / intrapartum |
| Feed / Milk Aspiration | Breast milk / formula | Postnatal |
| Neonatal Pneumonia (aspiration type) | Infected amniotic fluid / vaginal secretions | Peripartum |

Current guidelines (ILCOR/AAP) recommend against routine endotracheal suctioning for both vigorous AND depressed infants following MSAF delivery. Delay in PPV causes more harm than benefit.
| Infant Status | Management |
|---|---|
| Vigorous (good tone, HR ≥100, adequate respiratory effort) | Clear mouth and nose with bulb suction or large-bore catheter only; dry and return to mother |
| Non-vigorous / Depressed (poor tone, HR <100, poor respiratory effort) | Warm, open airway, stimulate; if not improving → Positive Pressure Ventilation (PPV) immediately |
Tracheal suctioning in depressed infants born through MSAF does NOT reduce morbidity or mortality - current evidence does NOT support this practice.
| Step | Action |
|---|---|
| 1. Warm, dry, stimulate | For all infants |
| 2. Assess: tone, HR, respiratory effort | Decision point |
| 3a. If vigorous | Bulb suction nose/mouth only; routine care |
| 3b. If non-vigorous + HR <100 or apnea/gasping | PPV with bag-mask immediately; room air first |
| 4. If no improvement with PPV | Intubate; begin chest compressions if HR <60 after 30s of effective ventilation |
| 5. Target SpO2 (preductal) | 1 min: 60-65%; 5 min: 80-85%; 10 min: 85-90% |
| Time After Birth | Target SpO2 (preductal) |
|---|---|
| 1 min | 60-65% |
| 2 min | 65-70% |
| 3 min | 70-75% |
| 4 min | 75-80% |
| 5 min | 80-85% |
| 10 min | 85-90% |
| Severity | Treatment |
|---|---|
| Mild | Supplemental O2, close monitoring |
| Moderate | CPAP or nasal cannula high-flow O2 |
| Severe (needing PPV) | Mechanical ventilation (~30% of affected infants) |
| Pulmonary hypertension | Inhaled nitric oxide (iNO) - first-line for PPHN in MAS |
| Refractory to iNO | Extracorporeal membrane oxygenation (ECMO) - VA or VV method |
| Strategy | Evidence |
|---|---|
| Induction at 41 weeks | Reduces MSAF and MAS incidence (systematic review data) |
| Amnioinfusion | Does NOT reduce MAS in settings with adequate peripartum surveillance |
| Prophylactic antibiotics to mother | Reduces chorioamnionitis but does NOT reduce neonatal sepsis or NICU admissions |
| Routine oropharyngeal/tracheal suctioning at delivery | No longer recommended - abandoned since 2015 guidelines |
| Skilled resuscitation team at high-risk deliveries | Required at all deliveries with MSAF |
Diaper of baby Bio medical waste management
baby diaper biomedical waste management classification hospital WHO guidelines 2024
India biomedical waste management rules 2016 diaper nappy category soiled waste hospital
https://www.legitquest.com/act/bio-medical-waste-management-…
| Setting | Contamination | Classification |
|---|---|---|
| Home / Community | Urine + feces only | Sanitary / Solid Waste (Municipal) |
| Hospital / NICU / Clinic | Urine + feces (no blood) | Soiled Waste → Yellow Category (BMW Rules) |
| Hospital / NICU / Clinic | Contaminated with blood or body fluids | Infectious Soiled Waste → Yellow Category (BMW Rules) |
| Home - diaper contaminated with blood | Blood-contaminated | Should be treated as biomedical-type / infectious waste |
| Color | Category | Type of Waste | Includes Diapers? | Treatment & Disposal |
|---|---|---|---|---|
| 🟡 Yellow | Anatomical, soiled, microbiological | Human anatomical waste, soiled waste (items contaminated with blood/body fluids - dressings, cotton swabs, plaster casts), expired medicines, discarded linen | Yes - hospital diapers contaminated with blood/fluid | Incineration or plasma pyrolysis or deep burial; in absence, autoclaving + shredding |
| 🔴 Red | Contaminated recyclable waste | Tubing, IV sets, syringes (without needle), catheters, urine bags | No | Autoclaving/microwaving + recycling |
| ⬜ White (Translucent) | Sharps | Needles, syringes with needle, lancets, scalpel blades | No | Shredding + encapsulation |
| 🔵 Blue | Glassware | Broken glass, medicine vials, ampoules | No | Disinfection + recycling |
Hospital diapers from the neonatal ward/NICU fall under Yellow Category - Soiled Waste when contaminated with blood or body fluids. Urine/stool-only diapers in hospital settings are still handled as Yellow category soiled waste in practice due to infectious pathogen risk.
"Items contaminated with blood, body fluids like dressings, plaster casts, cotton swabs and bags containing residual or discarded blood and blood components."
| WHO Category | Examples |
|---|---|
| Infectious waste | Items contaminated with blood, secretions, excretions from infectious patients |
| Pathological waste | Tissues, organs, body parts, fetus |
| Sharps | Needles, scalpels |
| Pharmaceutical waste | Expired medicines |
| Chemical waste | Lab reagents, disinfectants |
| General / Non-hazardous | ~85% of all healthcare waste - food wrappers, non-contaminated paper, non-contaminated diapers |
Hospital diapers with blood/infectious body fluid = Infectious waste (WHO) Urine/stool only diapers in non-infectious patients = can be classified General waste per WHO, but most hospital protocols treat all neonatal ward diapers as infectious/soiled waste for safety.
| Point | Detail |
|---|---|
| Hospital neonatal diapers | Yellow bag (India) / Red biohazard bag (US) |
| Home diapers | Wrap and place in non-biodegradable/dry waste (India SWM Rules) |
| Maximum storage time | 48 hours for soiled yellow-category waste |
| Never mix | BMW bags must never be mixed with general waste |
| Staff protection | Gloves mandatory; hand hygiene after every diaper change |
| Documentation | Hospital must maintain BMW register updated daily |
| Reporting | Major BMW accidents must be reported to SPCB within 24 hours |
Clinical Note for NICU/Neonatal Ward Staff: All diapers from newborns in clinical settings should be treated as yellow-category soiled biomedical waste by default, regardless of visible blood contamination, as neonatal feces may contain viral pathogens (Rotavirus, Norovirus, GBS, etc.) capable of nosocomial transmission.
Bp 185/95 hr 89 in old adult
hypertension older adults treatment guidelines
PMID: 39688187
| Parameter | Value | Interpretation |
|---|---|---|
| Systolic BP | 185 mmHg | Stage 2 Hypertension (≥140 mmHg) |
| Diastolic BP | 95 mmHg | Stage 2 Hypertension (≥90 mmHg) |
| Heart Rate | 89 bpm | Normal sinus range (60-100 bpm) |
| Pulse Pressure | 90 mmHg | Wide - suggests reduced arterial compliance (common in elderly) |
Note: In older adults, isolated systolic hypertension (ISH) is the most common pattern due to age-related arterial stiffness. This patient has both systolic AND diastolic elevation, making it combined hypertension.
| Feature | Hypertensive Urgency | Hypertensive Emergency |
|---|---|---|
| BP | ≥180/120 mmHg | ≥180/120 mmHg |
| End-organ damage | ABSENT | PRESENT |
| Symptoms | Headache, anxiety | See below |
| Management | Oral meds, outpatient | IV medications, ICU |
| BP reduction goal | Gradual over 24-48 hrs | 10-20% in 1st hour |
This patient's BP is 185/95 - the systolic qualifies for urgent evaluation. The key differentiator is end-organ damage, NOT the BP number alone.
| System | Symptoms/Signs to Assess | Indicates |
|---|---|---|
| Brain | Headache (esp. occipital), confusion, visual changes, focal deficits, seizures | Hypertensive encephalopathy, stroke |
| Eyes | Blurred vision, sudden visual loss | Hypertensive retinopathy, papilledema |
| Heart | Chest pain, shortness of breath, orthopnea | ACS, acute heart failure/pulmonary edema |
| Aorta | Tearing chest/back pain, BP difference between arms | Aortic dissection |
| Kidneys | Oliguria, hematuria | Acute kidney injury |
| Test | Purpose |
|---|---|
| ECG | LVH (voltage criteria), ischemia |
| Urinalysis | Proteinuria, hematuria (renal damage) |
| Serum creatinine + eGFR | Renal function |
| Electrolytes (Na+, K+) | Hypokalemia → hyperaldosteronism? |
| Fasting glucose / HbA1c | Diabetes co-morbidity |
| Lipid profile | Cardiovascular risk stratification |
| CBC | Microangiopathic hemolytic anemia (in emergency) |
| Chest X-ray | Cardiomegaly, pulmonary congestion, aortic dilation |
| Echo (if indicated) | LVH, systolic/diastolic function |
| Spot urine albumin:creatinine | Early nephropathy |
Practical consensus: For most older adults with BP 185/95, start treatment and aim for <140-150/90 mmHg, with caution in frail, very elderly patients (>80 years) or those with known CAD (where excessive DBP lowering risks myocardial ischemia - J-curve effect).
| Intervention | Expected SBP Reduction |
|---|---|
| Salt restriction (<2g Na/day) | 5-6 mmHg |
| DASH diet | 8-14 mmHg |
| Weight reduction (per 10 kg lost) | 5-20 mmHg |
| Regular aerobic exercise (30 min, 5x/week) | 4-9 mmHg |
| Limit alcohol | 2-4 mmHg |
| Smoking cessation | Cardiovascular risk reduction |
| Drug Class | Examples | Notes for Elderly |
|---|---|---|
| Thiazide / Thiazide-like diuretics | Chlorthalidone 12.5-25mg, Indapamide 1mg | Preferred; chlorthalidone preferred (longer half-life) |
| ACE Inhibitors | Enalapril 5-40mg, Lisinopril 10-40mg, Ramipril 2.5-20mg | Avoid if bilateral RAS; contraindicated in pregnancy; can cause hyperkalemia in elderly with CKD |
| ARBs | Losartan 50-100mg, Valsartan 80-320mg, Olmesartan | Alternative to ACEi if cough; don't combine with ACEi |
| CCB (DHP) | Amlodipine 2.5-10mg, Felodipine | Particularly useful in isolated systolic HTN; watch for ankle edema |
| Beta-blockers | Metoprolol succinate, Carvedilol | Second-line unless concurrent CAD, HF, or HR control needed; atenolol less preferred |
For this patient (BP 185/95, HR 89): A combination of a thiazide-like diuretic + ACEi/ARB or CCB is a reasonable first choice. Beta-blocker is not first-line for HTN alone (HR 89 is already normal) but would be useful if there is concurrent heart failure or CAD.
| Issue | Consideration |
|---|---|
| Orthostatic hypotension | Check standing BP; common in elderly; avoid over-treatment |
| Falls risk | Aggressive BP lowering increases fall/fracture risk |
| Polypharmacy | Check for drug interactions; NSAIDs, decongestants raise BP |
| White coat hypertension | Confirm with home BP monitoring or 24-hr ABPM |
| Frailty | Frail patients may benefit from higher BP targets (<150/90 mmHg) |
| Cognitive function | Hypertension is a major risk factor for vascular dementia; treating reduces progression |
| CKD (common in elderly) | ACEi/ARB preferred if proteinuria; monitor K+ and creatinine |
| Isolated systolic HTN | Most common pattern in elderly; treat the systolic; do not over-lower diastolic |
BP 185/95, HR 89 in older adult
↓
1. ASSESS: Any end-organ damage symptoms?
↓
YES → Hypertensive Emergency → IV labetalol/nicardipine → ICU
NO → Hypertensive Urgency OR Stage 2 HTN
↓
2. CONFIRM BP on 2-3 occasions (both arms); check for white coat HTN
↓
3. INVESTIGATE: ECG, urinalysis, renal function, electrolytes, lipids, glucose
↓
4. TREAT:
- Lifestyle modification (DASH diet, salt restriction, exercise)
- Combination antihypertensive therapy:
Thiazide + ACEi/ARB OR Thiazide + CCB
- Target: SBP <140-150 mmHg, DBP ≥60-65 mmHg
- Monitor for orthostatic hypotension and falls
↓
5. FOLLOW UP in 2-4 weeks to reassess BP and medication tolerability
Recent evidence note (Cochrane 2024, PMID 39688187): In adults ≥65 years, there is insufficient evidence that targeting BP <140/90 mmHg is better than targeting <150-160 mmHg for hard outcomes (mortality, stroke, cardiovascular events). Individualize targets, especially in frail or very elderly patients (>80 years).
S. Billirubin total is 8.6 mg/dl
hyperbilirubinemia diagnosis differential management adult
PMID: 39823630
| Parameter | Normal Range | This Patient | Interpretation |
|---|---|---|---|
| Total bilirubin | 0.2 - 1.2 mg/dL | 8.6 mg/dL | Markedly elevated (7.2x ULN) |
| Direct (conjugated) | 0 - 0.3 mg/dL | Not yet known | Must be fractionated |
| Indirect (unconjugated) | 0.2 - 0.9 mg/dL | Not yet known | Must be fractionated |
Jaundice (icterus) becomes clinically visible in the sclera and skin when total bilirubin exceeds 3.0 mg/dL. At 8.6 mg/dL, the patient will have obvious jaundice. Tea-colored or dark urine suggests conjugated (direct) hyperbilirubinemia.

| Fraction Dominant | Type | Mechanism | Broad Category |
|---|---|---|---|
| Indirect > 85% of total | Unconjugated hyperbilirubinemia | Overproduction, impaired uptake, or impaired conjugation | Pre-hepatic or hepatic (conjugation defect) |
| Direct > 15-50% of total | Conjugated hyperbilirubinemia | Impaired excretion (intrahepatic) or biliary obstruction (extrahepatic) | Hepatic or post-hepatic |
Normally, >90% of serum bilirubin is unconjugated. Conjugated bilirubin in urine = conjugated hyperbilirubinemia = hepatobiliary disease (unconjugated bilirubin is bound to albumin and NEVER appears in urine).
| Category | Conditions |
|---|---|
| Hemolytic disorders (Inherited) | Sickle cell disease, Spherocytosis/elliptocytosis, G6PD deficiency, Thalassemia |
| Hemolytic disorders (Acquired) | Autoimmune hemolytic anemia, Microangiopathic hemolysis (TTP/HUS/DIC), Malaria, Transfusion reactions |
| Ineffective erythropoiesis | Megaloblastic anemia, Thalassemia |
| Resorption of large hematoma | Post-trauma, post-surgery |
| Impaired hepatic uptake | Drugs (rifampicin, probenecid), sepsis |
| Impaired conjugation (inherited) | Gilbert syndrome (most common - 6-12% prevalence), Crigler-Najjar Type I & II |
Note: Gilbert syndrome typically causes only mild elevation (rarely >5 mg/dL), usually triggered by fasting, stress, or illness. A total bilirubin of 8.6 mg/dL is too high for typical Gilbert's alone - another cause must be sought.
| Condition | Key Features |
|---|---|
| Viral hepatitis (A, B, C, E) | Fever, malaise, elevated ALT/AST (hepatocellular pattern) |
| Alcoholic liver disease | Alcohol history, AST:ALT ratio >2:1, GGT elevated |
| Drug-induced liver injury (DILI) | Medication history review essential |
| Autoimmune hepatitis | Young/middle-aged women, elevated IgG, ANA/ASMA |
| Primary biliary cholangitis (PBC) | Middle-aged women, elevated ALP/GGT, anti-mitochondrial antibody |
| Cirrhosis / acute liver failure | Coagulopathy, low albumin, encephalopathy |
| Ischemic hepatitis | "Shock liver"; massive ALT/AST rise (>10,000 U/L) |
| Sepsis-associated cholestasis | Systemic infection, predominantly direct bilirubin |
| Wilson's disease | Young patient, Kayser-Fleischer rings, neuropsychiatric symptoms |
| Dubin-Johnson / Rotor syndrome | Isolated conjugated hyperbilirubinemia; benign hereditary |
| Condition | Key Features |
|---|---|
| Choledocholithiasis | Colicky RUQ pain, fever, elevated ALP/GGT; Charcot's triad if cholangitis |
| Cholangitis (ascending) | Charcot's triad: fever + RUQ pain + jaundice; Reynold's pentad (+hypotension + confusion) = severe |
| Pancreatic cancer | Painless progressive jaundice, weight loss, palpable gallbladder (Courvoisier's sign) |
| Cholangiocarcinoma | Progressive jaundice, biliary dilation on imaging |
| Primary sclerosing cholangitis (PSC) | Associated with IBD (ulcerative colitis), beaded bile ducts on MRCP |
| Biliary stricture | Post-surgical or inflammatory |
| Ampullary carcinoma | Periampullary tumor; intermittent jaundice |
| Test | Purpose |
|---|---|
| Fractionated bilirubin (direct + indirect) | Mandatory first step - guides entire workup |
| ALT, AST | Hepatocellular damage marker (elevation pattern) |
| ALP, GGT | Cholestatic/obstructive pattern |
| Albumin | Hepatic synthetic function |
| PT/INR | Hepatic synthetic function (best test) |
| CBC with differential | Hemolysis (anemia, reticulocytosis), infection (leukocytosis) |
| Urinalysis | Bilirubinuria = conjugated hyperbilirubinemia |
| Serum creatinine | Renal function (hepatorenal syndrome?) |
| Pattern | ALT/AST | ALP/GGT | Bilirubin | Suggests |
|---|---|---|---|---|
| Hepatocellular | Very high (>10x ULN) | Normal or mildly ↑ | Both fractions ↑ | Hepatitis, ischemia, DILI |
| Cholestatic | Normal or mildly ↑ | High (>3x ULN) | Predominantly direct | Obstruction, PBC, drugs |
| Mixed | Both elevated | Both elevated | Both fractions ↑ | Cirrhosis, sepsis |
| Modality | When to Use | Detects |
|---|---|---|
| Abdominal Ultrasound | First-line for ALL jaundice | Gallstones, bile duct dilation, liver texture, masses |
| CT abdomen with IV contrast | If US inconclusive or mass suspected | Pancreatic/liver tumors, lymphadenopathy |
| MRCP | Biliary tree detail without contrast | Choledocholithiasis, PSC, cholangiocarcinoma |
| ERCP | Therapeutic (stone removal, stenting) | Biliary obstruction - also treats it |
| Liver biopsy | If etiology unclear after labs + imaging | Histological diagnosis (hepatitis, cirrhosis, DILI) |
Per 2025 AFP review (PMID 39823630): "Ultrasonography of the abdomen, CT with IV contrast, and MRCP are first-line imaging options depending on suspected etiology. If etiology remains unclear despite lab testing and imaging, liver biopsy may be required."
| Suspected cause | Test |
|---|---|
| Viral hepatitis | Hep A IgM, HBsAg, Anti-HCV, Hep E IgM |
| Hemolysis | Reticulocyte count, haptoglobin (↓), LDH (↑), peripheral blood smear |
| Autoimmune hepatitis | ANA, ASMA, IgG |
| PBC | Anti-mitochondrial antibody (AMA), IgM |
| PSC | pANCA, MRCP |
| Wilson's disease | Serum ceruloplasmin, 24-hr urine copper, slit-lamp exam |
| Hemochromatosis | Serum ferritin, transferrin saturation |
Total bilirubin 8.6 mg/dL → Clinically jaundiced
↓
1. FRACTIONATE BILIRUBIN
↓
┌──────────────────────────────────┐
│ Predominantly INDIRECT │ Predominantly DIRECT
│ (<15% direct) │ (≥15-50% direct)
│ │
│ → Hemolysis workup │ → LFT pattern analysis
│ (haptoglobin, LDH, smear) │ (hepatocellular vs cholestatic)
│ → Drug review │ → Ultrasound abdomen
│ → Gilbert's / Crigler-Najjar │ → Viral/autoimmune serology
└──────────────────────────────────┘
↓
2. ABDOMINAL ULTRASOUND (all cases)
↓
3. ALT, AST, ALP, GGT, PT/INR, Albumin, CBC, Urine bilirubin
↓
4. Directed additional tests (MRCP, CT, liver biopsy) per findings
Clinical Pearl: Bilirubin 8.6 mg/dL with elevated ALP/GGT and dilated bile ducts on ultrasound = obstructive jaundice until proven otherwise - requires urgent MRCP/ERCP. With markedly elevated ALT/AST and no duct dilation = hepatocellular injury - focus on hepatitis, DILI, autoimmune causes.
Baby age 5day and blood urea 62 and serum ceritinine is 1.0 and he is viattly stable and CRP is negative
neonatal acute kidney injury creatinine reference values newborn
neonatal AKI diagnosis criteria serum creatinine
PMID: 41504897
neonatal day 5 serum creatinine 1.0 blood urea 62 normal range AKI criteria 2024
https://www.safercare.vic.gov.au/best-practice-improvement/c…
| Age | Normal Urea (mmol/L) | Normal Urea (mg/dL approximate) |
|---|---|---|
| Day 1-7 (term) | 1.1 - 9.1 mmol/L | ~6.6 - 54.7 mg/dL |
| Day 21+ | 0.8 - 11.2 mmol/L | ~4.8 - 67.2 mg/dL |
This baby's blood urea 62 mg/dL = ~22 mmol/L, which is above the upper limit of 9.1 mmol/L (~54.7 mg/dL) for the first week. This is elevated but not critically so.
| Age | Expected Serum Creatinine |
|---|---|
| Birth (day 1) | 0.6-1.2 mg/dL (reflects maternal creatinine - passively transferred across placenta) |
| Day 3-5 | Should be falling toward 0.5-0.8 mg/dL |
| Day 7-14 | ~0.3-0.7 mg/dL |
| 1 month | ~0.2-0.4 mg/dL |
| 1 year | ~0.2-0.4 mg/dL |
Key Concept: In the first 2-3 days, serum creatinine in a term newborn mirrors the mother's creatinine. It then progressively falls as the baby's own kidneys take over. By day 5, creatinine of 1.0 mg/dL is borderline-high - it should be falling. If it is NOT falling (or rose from a lower earlier value), this is a red flag.
| Stage | Serum Creatinine Criterion | Urine Output Criterion |
|---|---|---|
| Stage 1 | Rise ≥ 0.3 mg/dL within 48 hrs OR rise 1.5-1.9× baseline (days 2-7) | < 0.5 mL/kg/h for 6-12 hours |
| Stage 2 | Rise 2.0-2.9× baseline | < 0.5 mL/kg/h for ≥12 hours |
| Stage 3 | Rise ≥ 3× baseline OR SCr ≥ 2.5 mg/dL OR dialysis | ≤ 0.3 mL/kg/h for ≥24 hrs OR anuria ≥12 hrs |
Important: For neonates, the "baseline" = the lowest previous SCr value in days 2-7 (day of birth = day 1). So if SCr was 0.8 on day 3 and is now 1.0 on day 5 - that's a rise of 0.2 mg/dL which approaches Stage 1 territory. If it was 0.6 mg/dL and is now 1.0 mg/dL - that's a 1.67× rise = Stage 1 AKI.
| BUN (mg/dL) | Creatinine (mg/dL) | Ratio | Interpretation |
|---|---|---|---|
| 62 | 1.0 | 62:1 | Strongly suggests pre-renal (dehydration, poor intake) |
| Test | Purpose |
|---|---|
| Serial serum creatinine (repeat in 24-48h) | Is creatinine falling? If yes → likely physiological/pre-renal resolving |
| Urine specific gravity | >1.020 = concentrated urine = dehydration / pre-renal |
| Urine:plasma creatinine ratio | High = pre-renal (kidneys concentrating) |
| Urine sodium | Low (<20 mEq/L) = pre-renal; High (>40 mEq/L) = intrinsic renal |
| Fractional excretion of sodium (FeNa) | <2.5% in neonates = pre-renal |
| Electrolytes (Na, K, Ca, PO4) | Hyperkalemia, hyponatremia in AKI |
| Renal ultrasound | Structural anomalies, hydronephrosis |
| Blood gas | Metabolic acidosis in AKI |
| Full blood count | Hemolysis, polycythemia |
| Parameter | This Baby | Interpretation |
|---|---|---|
| Blood urea 62 mg/dL | Upper limit of neonatal normal (~54 mg/dL) - mildly elevated | Suggests dehydration/pre-renal or reduced intake |
| Creatinine 1.0 mg/dL | Borderline-high for day 5 (should be falling) | Needs serial monitoring - is it falling? |
| BUN:Cr ratio 62:1 | Very high | Strongly suggests pre-renal/dehydration |
| CRP negative | No infection | Sepsis unlikely |
| Vitally stable | Good sign | Not in shock |
Most probable diagnosis: Neonatal dehydration with pre-renal azotemia - likely due to inadequate breastfeeding intake in the first week. This is a common and correctable condition. The critical next step is to check the baby's weight loss from birth, urine output, and repeat renal function after hydration optimization.
⚠ Red flag: If creatinine on repeat testing is NOT falling - or if urine output is <1 mL/kg/hr despite adequate feeding - escalate to neonatologist and arrange renal ultrasound to exclude structural anomaly.
Preterm neonate is dull and spo2 is 97 blood sugar is 38 , RR is 50 , HR 140 , temp 36.9
neonatal hypoglycemia management treatment guidelines preterm
| Parameter | Value | Neonatal Normal | Interpretation |
|---|---|---|---|
| Level of consciousness | Dull | Alert, active | 🔴 ABNORMAL - major red flag |
| SpO2 | 97% | 95-100% (room air) | ✅ Acceptable |
| Blood Sugar | 38 mg/dL | >45-50 mg/dL (neonate) | 🔴 HYPOGLYCEMIA - symptomatic |
| RR | 50 breaths/min | 40-60/min (neonate) | 🟡 Upper normal / borderline tachypnea |
| HR | 140 bpm | 120-160 bpm (neonate) | 🟡 Normal range / slightly elevated |
| Temperature | 36.9°C | 36.5-37.5°C | ✅ Normal |
Per Rosen's Emergency Medicine: "Neonates with a glucose level less than 40 mg/dL and with symptoms of hypoglycemia - irritability, tremors, jitteriness, apnea, tachypnea, seizures, cyanosis, lethargy, poor feeding - require treatment with IV glucose."
| Diagnosis | Supporting Features | How to Evaluate |
|---|---|---|
| 🔴 Symptomatic hypoglycemia | BSL 38 + lethargy | Confirmed - treat immediately |
| Neonatal sepsis (early/late onset) | Tachycardia 140, RR 50, preterm, lethargy | CRP (repeat), CBC, blood culture, consider empiric antibiotics |
| Respiratory distress syndrome (RDS) | Preterm, RR 50, may have grunting/retractions | CXR, SpO2 trend, work of breathing |
| Hypothermia (mild/occult) | Dull preterm | Core temperature, incubator check |
| Hypoxic-ischemic encephalopathy | Birth history, Apgar scores | Birth history review |
| Metabolic/electrolyte disorder | Hypo-natremia, hypocalcemia | Electrolytes, calcium |
| Intraventricular hemorrhage (IVH) | Very preterm + sudden deterioration | Head ultrasound |
| Polycythemia | Ruddy appearance, hematocrit >65% | Hematocrit/CBC |
Do NOT use D50W in neonates - causes rebound hypoglycemia and osmotic injury. D10W is standard for neonates.
GIR (mg/kg/min) = [% dextrose × infusion rate (mL/hr)] ÷ [weight (kg) × 6]
| Investigation | Purpose |
|---|---|
| Blood glucose (bedside glucometer + lab confirmation) | Hypoglycemia confirmed |
| Full blood count (CBC) | Sepsis screen (WBC, neutrophil:lymphocyte ratio, platelets) |
| C-reactive protein (CRP) - if not done recently | Infection marker |
| Blood culture x2 | Before starting antibiotics |
| Electrolytes: Na, K, Ca, Mg | Electrolyte disturbances |
| Blood gas (capillary or arterial) | Acidosis, CO2, respiratory status |
| Chest X-ray | RDS, pneumonia, cardiac |
| Bilirubin | Preterm jaundice |
| Head ultrasound | If very preterm or deteriorating - IVH |
| Drug | Dose | Route | Frequency |
|---|---|---|---|
| Ampicillin | 50-100 mg/kg | IV | Every 12h (preterm <1 week) |
| Gentamicin | 4-5 mg/kg | IV | Every 36-48h (preterm, adjust by GA) |
| Feature | Significance |
|---|---|
| Grunting (expiratory) | Splinting to maintain FRC - suggests RDS |
| Nasal flaring | Increased work of breathing |
| Intercostal/subcostal retractions | Significant respiratory distress |
| Apnea spells | Very concerning in preterm |
| Cyanosis | SpO2 may not capture brief episodes |
PRETERM NEONATE - DULL, BSL 38, RR 50, HR 140, SpO2 97%, Temp 36.9°C
↓
🔴 IMMEDIATE:
1. IV access → D10W 2 mL/kg bolus IV over 5-10 min
2. Follow with D10W infusion 80-100 mL/kg/day (GIR 5-7 mg/kg/min)
3. Recheck glucose at 15-30 minutes
↓
🟡 WITHIN 30 MINUTES:
4. Blood culture x2, CBC, CRP, electrolytes, blood gas
5. Chest X-ray
6. Place in incubator - maintain temperature
7. Start empiric antibiotics if sepsis suspected:
Ampicillin + Gentamicin IV
↓
🟢 ONGOING MONITORING:
8. Continuous SpO2, HR, RR, temperature
9. Blood glucose every 30 min until stable >50 mg/dL
10. Urine output monitoring (>1 mL/kg/hr)
11. Head ultrasound if very preterm or neurological concern
12. Neonatologist / NICU referral immediately
"Dull" preterm + glucose 38 = treat first, investigate simultaneously. Every minute of hypoglycemia in a preterm causes ongoing risk of neurological injury - glucose is neuroprotective.
CRP negative does NOT rule out sepsis in the first 12-24 hours. Serial CRP (repeat at 12-24h) + CBC + blood culture are the minimum.
Tachycardia (140 bpm) in a preterm is a non-specific but important sign - can be caused by hypoglycemia itself, pain, fever, sepsis, hypovolemia, or cardiac causes.
Refractory hypoglycemia (glucose not responding to D10W infusion at GIR >10 mg/kg/min) should prompt investigation for hyperinsulinism, cortisol deficiency, growth hormone deficiency, or inborn errors of metabolism.
neonate after delivery is dull and spo2 is 97 blood sugar is 38 , RR is 50 , HR 140 , temp 36.9 , weight 1.7 kg colur pink and oral secretion in mouth, crt less than 3 sec
| Question | This Baby | Answer |
|---|---|---|
| Term gestation? | 1.7 kg → likely preterm (28-34 weeks) | ❌ NO |
| Good tone? | Dull = reduced tone | ❌ NO |
| Breathing or crying? | Not specified / dull → poor respiratory effort likely | ❌ NO |
Because the answer is NO to at least one question → baby goes under radiant warmer for initial steps immediately. Do NOT leave with mother.

| Parameter | Value | Normal (Neonate) | Assessment |
|---|---|---|---|
| Weight | 1.7 kg | Term: 2.5-4.0 kg | 🔴 Preterm / LBW |
| Tone/consciousness | Dull | Alert, active, good tone | 🔴 ABNORMAL |
| Color | Pink | Pink centrally | ✅ Good |
| SpO2 | 97% | 85-95% at 10 min (see targets below) | ✅ Acceptable |
| Blood Sugar | 38 mg/dL | >45 mg/dL | 🔴 HYPOGLYCEMIA |
| RR | 50/min | 40-60/min | 🟡 Upper normal |
| HR | 140 bpm | 120-160 bpm | ✅ Normal |
| Temp | 36.9°C | 36.5-37.5°C | ✅ Normal |
| CRT | <3 sec | <3 sec | ✅ Perfusion adequate |
| Oral secretions | Present | Should be cleared if obstructing | 🟡 Clear if needed |
| Post-stimulation finding | Action |
|---|---|
| Breathing adequately, HR >100, improving tone | → Post-resuscitation care + treat hypoglycemia |
| Still dull, poor effort, HR >100 | → Supplemental O2 + SpO2 monitor + consider CPAP |
| Apnea or HR <100 bpm | → Start PPV immediately |
| Sign | 0 | 1 | 2 | This Baby (estimated) |
|---|---|---|---|---|
| Heart rate | Absent | <100 | ≥100 | 2 (HR 140) |
| Respiratory effort | Absent | Weak, irregular | Good, crying | 1 (dull, weak) |
| Muscle tone | Limp | Some flexion | Active motion | 1 (dull) |
| Reflex irritability | None | Grimace | Cry/cough | 1 (reduced) |
| Color | Blue/pale | Blue extremities | Pink all over | 2 (pink) |
| Estimated APGAR | ~7/10 at 1 min |
APGAR 7-10 = good; 4-6 = moderate depression; 0-3 = severe depression. This baby is likely borderline 7, pending actual respiratory effort assessment.
| Time After Birth | Target SpO2 |
|---|---|
| 1 min | 60-65% |
| 2 min | 65-70% |
| 3 min | 70-75% |
| 4 min | 75-80% |
| 5 min | 80-85% |
| 10 min | 85-95% |
SpO2 97% may actually be too high if measured in first few minutes - healthy newborns take 10 minutes to reach normal oxygen saturation. Avoid supplemental O2 unless SpO2 is below target range for age. Hyperoxia in preterm = risk of retinopathy of prematurity (ROP) and chronic lung disease.
| Step | Action |
|---|---|
| IV access | Peripheral IV or Umbilical Venous Catheter (UVC - preferred in preterm) |
| Dextrose bolus | D10W 2 mL/kg = 3.4 mL IV over 5 minutes |
| Maintenance infusion | D10W at 80 mL/kg/day = 5.7 mL/hour for 1.7 kg |
| Glucose Infusion Rate (GIR) | Target 4-6 mg/kg/min initially |
| Recheck glucose | 15-30 minutes after bolus |
| Target BSL | >50 mg/dL (ideally >60 mg/dL in preterm) |
GIR = (% dextrose × rate in mL/hr) ÷ (weight kg × 6)
D10W at 5.7 mL/hr in 1.7 kg = (10 × 5.7) ÷ (1.7 × 6) = 57 ÷ 10.2 = 5.6 mg/kg/min ✅
NEVER use D50W or D25W in neonates - causes hyperosmolarity and rebound hypoglycemia. Use D10W only.
| Birth Weight | Gestational Age | ETT Size (uncuffed) | Depth of Insertion |
|---|---|---|---|
| 1-2 kg | 28-34 weeks | 3.0 mm | 8 cm at lip |
1.7 kg PRETERM NEWBORN - DULL, ORAL SECRETIONS, BSL 38
↓
🔴 IMMEDIATE (0-30 sec):
✅ Warm under radiant warmer
✅ Sniffing position
✅ Suction MOUTH then NOSE (secretions present)
✅ Dry and stimulate (rub back, flick feet)
✅ SpO2 probe on right hand
↓
⏱ AT 60 SECONDS: Reassess
HR >100? → YES (140) ✅
Breathing? → Assess after stimulation
Cyanosis? → No (pink) ✅
↓
IF STILL DULL BUT BREATHING:
→ Supplemental O2 to target SpO2
→ Consider CPAP (PEEP 5-6 cmH2O) for preterm
→ Get IV access / UVC
→ Treat hypoglycemia: D10W 3.4 mL IV bolus, then D10W infusion
→ Keep warm in incubator
→ NICU transfer
↓
IF APNEA OR HR <100 AFTER STIMULATION:
→ PPV with room air (21%) via face mask
→ Reassess HR at 15 sec
→ If no improvement → intubate (ETT 3.0mm, depth 8cm)
↓
FURTHER WORKUP:
→ Blood culture, CBC, CRP (sepsis screen)
→ Electrolytes, Ca, blood gas
→ Chest X-ray
→ Blood glucose every 30 min until stable
Dullness in a newborn = reduced tone = critical sign. Do not dismiss it. In a preterm, it is most commonly hypoglycemia, hypothermia, or both - both correctable. But sepsis and asphyxia must be excluded.
Oral secretions: only suction if obstructing airway. Suction mouth first, then nose. Keep suction <100 mmHg to avoid vagal bradycardia.
Pink color + HR 140 + CRT <3 sec are reassuring signs - this baby has adequate circulation and oxygenation at this moment.
Preterm 1.7 kg = high risk for: RDS, hypoglycemia, hypothermia, IVH, NEC, sepsis, apnea of prematurity. All need proactive monitoring in NICU.
Never start room air resuscitation with 100% O2 in preterm - use 21-30% O2 and titrate to SpO2 targets. Hyperoxia is harmful.
Preterm neonate is dull and spo2 is 97 blood sugar is 38 , RR is 50 , HR 140 , temp 36.9 , wbc 16000 , HB 16.0 , pletlates 85000
neonatal sepsis thrombocytopenia management preterm
neonatal WBC 16000 platelets 85000 preterm sepsis CBC interpretation normal range
| Parameter | Value | Neonatal Normal Range | Interpretation |
|---|---|---|---|
| Dull (tone/response) | Dull | Alert, active tone | 🔴 ABNORMAL |
| SpO2 | 97% | 91-95% in preterm | 🟡 Slightly high (watch for hyperoxia) |
| Blood Sugar | 38 mg/dL | >45-50 mg/dL | 🔴 SYMPTOMATIC HYPOGLYCEMIA |
| RR | 50/min | 40-60/min | 🟡 Upper normal - monitor |
| HR | 140 bpm | 120-160/min | ✅ Normal |
| Temp | 36.9°C | 36.5-37.5°C | ✅ Normal |
| WBC | 16,000/mm³ | 9,000-30,000 (term); 6,000-19,000 (preterm) | 🟡 Upper normal - NOT diagnostic alone |
| Hemoglobin | 16.0 g/dL | 14.5-19 g/dL (preterm, term) | ✅ Normal for neonate |
| Platelets | 85,000/mm³ | ≥150,000; rarely <100,000 in healthy newborns | 🔴 THROMBOCYTOPENIA |
| WBC Range (Neonate) | Interpretation |
|---|---|
| <5,000 | Leukopenia - HIGH risk of sepsis (LR 50-120x) |
| 5,000-19,000 | Normal range (preterm) |
| >20,000-30,000 | Leukocytosis - can be sepsis, stress, steroids |
| 16,000 | Upper range of normal - not diagnostic of sepsis alone |
Important: WBC alone has low positive predictive value for neonatal sepsis. A WBC of 16,000 does NOT confirm or exclude sepsis. Normal WBC counts are seen in up to 50% of culture-proven neonatal sepsis cases. The immature-to-total (I:T) neutrophil ratio >0.2 is far more specific - this requires the differential count.
| Platelet Count | Classification | Action |
|---|---|---|
| 150,000-400,000 | Normal | None |
| 100,000-149,000 | Mild thrombocytopenia | Monitor closely |
| 50,000-99,000 | Moderate thrombocytopenia | Investigate urgently - transfuse if bleeding |
| <50,000 | Severe thrombocytopenia | Transfuse immediately |
"The platelet count in the healthy newborn is rarely lower than 100,000/μL in the first 10 days of life. Thrombocytopenia (platelet count <100,000/μL) may be a presenting sign of neonatal sepsis and can last as long as 3 weeks; 10-60% of infants with sepsis have thrombocytopenia." - Medscape/Medline evidence
| Cause | Supporting Features | Probability |
|---|---|---|
| 🔴 Neonatal Sepsis (Early/Late onset) | Dullness + thrombocytopenia + preterm + borderline WBC | MOST LIKELY |
| Neonatal DIC | Complicating sepsis - consumption of platelets + coagulation factors | Concurrent with sepsis |
| Congenital infections (TORCH) | CMV: thrombocytopenia + petechiae + hepatosplenomegaly | Possible |
| Neonatal alloimmune thrombocytopenia (NAIT) | Maternal anti-HPA-1a antibodies; severe isolated thrombocytopenia | Less likely (usually severe, isolated) |
| Maternal ITP | Maternal history of ITP; passive transfer of IgG | Ask maternal history |
| Birth asphyxia | Consumptive thrombocytopenia | Check Apgar, birth history |
| Polycythemia | HB 16 is normal here - less likely | Low |
| Hypersplenism | Hepatosplenomegaly on exam | Examine abdomen |
| Metabolic disease | Propionic acidemia, MMA - rare | If workup negative |
| Criterion | Present? |
|---|---|
| Preterm gestation | ✅ YES |
| Dullness / altered consciousness | ✅ YES |
| Tachycardia (HR 140) | Borderline |
| Tachypnea (RR 50) | Borderline |
| Hypoglycemia (BSL 38) | ✅ YES (can be caused by sepsis) |
| Thrombocytopenia (plt 85K) | ✅ YES |
| WBC borderline | Soft |
Sepsis organisms in preterm (Early Onset <72h): Group B Streptococcus, E. coli, Klebsiella, Listeria Sepsis organisms in preterm (Late Onset >72h): CoNS, S. aureus, gram-negatives, Candida
| Step | Action for this baby (assume ~1.5-2 kg preterm) |
|---|---|
| Bolus | D10W 2 mL/kg IV over 5 min (e.g., 3-4 mL) |
| Infusion | D10W at 80-100 mL/kg/day (GIR 5-6 mg/kg/min) |
| Recheck BSL | 15-30 minutes after bolus |
| Target | BSL >50 mg/dL |
| Test | Purpose |
|---|---|
| Blood culture x2 (peripheral veins, 1 mL each) | Gold standard for sepsis |
| CBC with differential | I:T ratio (>0.2 = significant); absolute neutrophil count |
| CRP (if not already done / repeat) | Rises 6-12h after infection onset |
| Procalcitonin (PCT) | More sensitive early marker than CRP |
| Serum electrolytes (Na, K, Ca, Mg) | Electrolyte abnormalities |
| Blood gas | Metabolic acidosis (lactatemia in sepsis) |
| Coagulation screen (PT, aPTT, fibrinogen, D-dimer) | 🔴 IMPORTANT - platelets 85K → rule out DIC |
| LFTs + bilirubin | Hepatic involvement (CMV, sepsis) |
| Urinalysis + urine culture | Especially if >72h of age |
| Lumbar puncture | If clinically stable + sepsis confirmed or meningitis suspected |
| Chest X-ray | Pneumonia, RDS |
| Head ultrasound | IVH (very preterm) |
| Drug | Dose | Route | Frequency |
|---|---|---|---|
| Ampicillin | 50 mg/kg/dose | IV | Q12h (<1 week old, preterm) |
| Gentamicin | 4-5 mg/kg/dose | IV | Q36-48h (preterm, adjust by GA) |
Note: Cefotaxime preferred over ceftriaxone in neonates (ceftriaxone displaces bilirubin → kernicterus risk)
| Platelet Count | Bleeding? | Action |
|---|---|---|
| 85,000 + no active bleeding | None seen | Monitor; recheck in 12-24h |
| 85,000 + active bleeding | Yes | Platelet transfusion 10-15 mL/kg |
| 85,000 + coagulopathy (PT/aPTT elevated) | Any | Treat DIC: FFP 10-15 mL/kg + platelets |
| Falling trend | Rapid drop | Transfuse at <50,000 regardless of bleeding |
| Intervention | Detail |
|---|---|
| Incubator | Servo-controlled; appropriate temperature for GA |
| Continuous monitoring | SpO2, HR, RR, temperature, BP |
| SpO2 target in preterm | 91-95% (avoid hyperoxia - ROP risk) |
| Fluid balance | Monitor input/output strictly |
| Urine output | Target >1 mL/kg/hr |
| Oxygen | Only if SpO2 <91%; do NOT give O2 for SpO2 of 97% in stable preterm |
| NPO initially | If septic/unstable - hold enteral feeds until stabilized |
| NICU referral | Immediate - this baby needs NICU level care |
PRETERM NEONATE
├── DULL (lethargy) ──────────────────────────────── Sepsis / Hypoglycemia
├── BSL 38 mg/dL ─────────────────────────────────── Symptomatic Hypoglycemia
├── WBC 16,000 ────────────────────────────────────── Upper normal (not diagnostic alone)
├── Hb 16.0 g/dL ─────────────────────────────────── NORMAL for neonate
├── Platelets 85,000 ─────────────────────────────── 🔴 MODERATE THROMBOCYTOPENIA
├── HR 140, RR 50 ─────────────────────────────────── Borderline tachycardia/tachypnea
└── SpO2 97%, Pink, CRT <3 sec ────────────────────── Adequate perfusion/oxygenation
MOST LIKELY DIAGNOSIS: NEONATAL SEPSIS (Early or Late Onset)
with THROMBOCYTOPENIA ± early DIC
+ SYMPTOMATIC HYPOGLYCEMIA (contributing to dullness)
IMMEDIATE PRIORITIES:
1. D10W IV bolus → hypoglycemia
2. Blood culture, coagulation screen, full workup
3. Ampicillin + Gentamicin IV → empiric sepsis
4. Monitor platelets; transfuse if <50K or bleeding
5. NICU admission
Thrombocytopenia (plt <100K) is present in 10-60% of neonatal sepsis cases. In this preterm with dullness, it is a strong supporting sign of infection - even with a borderline normal WBC.
WBC of 16,000 alone does NOT diagnose or exclude sepsis. The differential (I:T ratio, ANC) matters more than the total count. A low WBC (<5,000) is actually more predictive of sepsis than a high count.
Always screen for DIC when platelets are low + sepsis suspected - get PT, aPTT, fibrinogen, D-dimers. Missing DIC and not giving FFP can be fatal.
Hypoglycemia in a septic neonate is both a symptom AND a worsening factor - treat it independently even while treating sepsis. The dullness may partly resolve once glucose is corrected.
Do NOT delay antibiotics waiting for CRP to turn positive - CRP has a 6-12 hour lag. Treat on clinical suspicion + platelet + culture results.
Type of seizures

| Type | Old Name | Awareness | Features |
|---|---|---|---|
| Focal Aware | Simple Partial | Preserved | Patient conscious; motor, sensory, autonomic, or psychic symptoms limited to one body area |
| Focal Impaired Awareness | Complex Partial | Impaired/Lost | Altered consciousness; automatisms (lip-smacking, hand-wringing); patient appears in a trance |
"A focal onset seizure can be preceded by telltale symptoms called auras. Common auras include unprovoked and often vivid sensations such as a sense of fear, a rising feeling in the abdomen, or even a specific odor." - Kandel's Principles of Neural Science 6th Edition
| Type | Features | Duration | Post-ictal |
|---|---|---|---|
| Tonic-Clonic (Grand Mal) | Most common motor type; tonic (rigid) phase → clonic (jerking) phase; may fall, cry out, bite tongue, lose bladder/bowel control, become cyanotic | 1-3 min | Yes - confusion, headache, fatigue, myalgia |
| Tonic | Sustained muscle stiffening (no clonic phase); may fall rigidly | Seconds | Brief |
| Clonic | Rhythmic jerking only (no tonic phase) | Seconds-minutes | Brief |
| Myoclonic | Brief (milliseconds), sudden muscle jerks; often bilateral; patient conscious | Milliseconds | None |
| Myoclonic-Tonic-Clonic | Myoclonic jerks followed by tonic-clonic | Variable | Yes |
| Myoclonic-Atonic | Myoclonic jerks + sudden loss of tone; "drop attack" | Seconds | Minimal |
| Atonic (Drop Attack) | Sudden complete loss of muscle tone → patient drops to ground | Seconds | Minimal |
| Epileptic Spasms | Brief flexion/extension spasms; seen in infants (West syndrome) | 1-2 sec | None |
| Type | Old Name | Features | EEG | Age |
|---|---|---|---|---|
| Typical Absence | Petit Mal | Abrupt staring, cessation of activity, brief (<10 sec), NO aura, NO post-ictal state, may have eye blinking | 3 Hz spike-and-wave | Children (4-12 yrs) |
| Atypical Absence | - | Longer duration, more gradual onset/offset, associated with intellectual disability | Slow spike-and-wave <2.5 Hz | Lennox-Gastaut syndrome |
| Myoclonic Absence | - | Absence + rhythmic myoclonic jerks of shoulder/arms | - | Childhood |
| Eyelid Myotonia | Jeavons syndrome | Eyelid jerking on eye closure + brief absence | - | Childhood |
"Typical absence seizures begin abruptly, usually last less than 10 seconds, are associated with staring and sudden cessation of all motor activity, and result in loss of awareness but not loss of posture. Unlike a focal onset seizure, there is no aura before the seizure or confusion after the seizure." - Kandel's Principles of Neural Science 6th Edition
| Type | Features |
|---|---|
| Unknown onset Tonic-Clonic | Tonic-clonic without known onset |
| Unknown onset Epileptic Spasms | Spasms with unknown onset |
| Behavior Arrest | Cessation of activity, unknown onset |
| Unclassified | Inadequate information |
SEIZURES
│
├── FOCAL ONSET
│ ├── Focal Aware (Simple Partial)
│ │ ├── Motor onset (clonic, tonic, myoclonic, automatisms, hyperkinetic)
│ │ └── Non-motor onset (sensory, autonomic, cognitive, emotional, behavior arrest)
│ │
│ ├── Focal Impaired Awareness (Complex Partial)
│ │ ├── Motor onset
│ │ └── Non-motor onset
│ │
│ └── Focal to Bilateral Tonic-Clonic (Secondary Generalization)
│
├── GENERALIZED ONSET
│ ├── Motor
│ │ ├── Tonic-Clonic (Grand Mal) ← most common motor
│ │ ├── Tonic
│ │ ├── Clonic
│ │ ├── Myoclonic
│ │ ├── Myoclonic-Tonic-Clonic
│ │ ├── Myoclonic-Atonic
│ │ ├── Atonic (Drop Attacks)
│ │ └── Epileptic Spasms
│ │
│ └── Non-Motor (Absence)
│ ├── Typical Absence (Petit Mal) ← most common non-motor
│ ├── Atypical Absence
│ ├── Myoclonic Absence
│ └── Eyelid Myotonia
│
└── UNKNOWN ONSET
├── Tonic-Clonic
├── Epileptic Spasms
├── Behavior Arrest
└── Unclassified
| Feature | Absence | Focal Impaired Awareness | Generalized Tonic-Clonic |
|---|---|---|---|
| Onset | Generalized | Focal (one hemisphere) | Generalized |
| Aura | ❌ None | ✅ Often present | ❌ None |
| Awareness | Lost briefly | Lost/impaired | Lost |
| Duration | <10 seconds | 1-3 minutes | 1-3 minutes |
| Automatisms | Mild (eye blinking) | Yes (complex) | No |
| Post-ictal | ❌ None | ✅ Yes (confusion) | ✅ Yes (prolonged) |
| Convulsions | ❌ None | Usually no | ✅ Yes (tonic+clonic) |
| EEG | 3Hz spike-wave | Focal temporal discharge | Generalized polyspike-wave |
| Age | Children | Any age | Any age |
| Common cause | Idiopathic | TLE, mesial temporal sclerosis | Idiopathic or symptomatic |
| Term | Definition |
|---|---|
| Ictal | During the seizure |
| Post-ictal | After the seizure (confusion, fatigue, Todd's paralysis) |
| Aura | Earliest subjective phase of a focal seizure |
| Todd's Paralysis | Transient focal weakness post-ictal (mimics stroke) |
| Status Epilepticus | Seizure lasting >5 minutes OR two or more seizures without recovery between them |
| Provoked seizure | Due to acute cause (fever, drugs, metabolic); not epilepsy |
| Epilepsy | Chronic condition of recurrent (≥2) unprovoked seizures |
| Age Group | Most Common Seizure Types |
|---|---|
| Neonates | Subtle (eye deviation, lip-smacking), clonic, tonic |
| Infants (3-12 months) | Epileptic spasms (West syndrome / infantile spasms) |
| Young children | Febrile seizures, absence epilepsy |
| Adolescents | Juvenile myoclonic epilepsy (JME) - myoclonic on awakening |
| Adults | Focal (complex partial) from temporal lobe - most common |
| Elderly | Focal seizures from stroke, tumor, neurodegenerative disease |
What is diagnostic work up and metabolic workup in neonatal in nicu
neonatal NICU diagnostic workup metabolic investigations preterm newborn standard protocol 2024
https://platform.who.int/docs/default-source/mca-documents/p…
neonatal NICU routine investigations metabolic screen ammonia lactate amino acids organic acids IEM newborn
NICU Workup
├── 1. Routine Admission Investigations
├── 2. Infection / Sepsis Screen
├── 3. Metabolic Panel (Basic)
├── 4. Hematological Screen
├── 5. Respiratory / Cardiac Assessment
├── 6. Neurological Investigations
├── 7. Metabolic Workup for IEM (Inborn Errors of Metabolism)
└── 8. Ongoing Monitoring / TPN Monitoring
| Test | Purpose | Normal Neonatal Value |
|---|---|---|
| Blood glucose (bedside glucometer) | Hypoglycemia screening | >45-50 mg/dL |
| Temperature | Hypothermia/hyperthermia | 36.5-37.5°C |
| Pulse oximetry | Oxygenation | 91-95% (preterm), 95-100% (term) |
| Birth weight, length, head circumference | Growth assessment | GA-appropriate |
| APGAR at 1 & 5 min | Perinatal condition | 7-10 = normal |
| Blood group + Rh type | Hemolytic disease of newborn (HDN) | - |
| Maternal blood group | Isoimmunization screen | - |
| Direct Coombs test (DAT) | HDN due to blood group incompatibility | Negative |
| Test | Purpose | Abnormal Values |
|---|---|---|
| Blood culture x2 | Gold standard - identify organism | Any growth |
| Full Blood Count (CBC) with differential | Leukopenia (<5,000), leukocytosis (>20,000) | WBC <5,000 or >20,000 |
| C-Reactive Protein (CRP) | Inflammation marker; rises 6-12h after infection | >10 mg/L = significant |
| Procalcitonin (PCT) | Earlier and more specific marker than CRP | >2 ng/mL = concern |
| I:T Ratio (immature:total neutrophil) | Immature neutrophil excess = sepsis | >0.2 = significant; >0.4 = clearly abnormal |
| Absolute Neutrophil Count (ANC) | Neutropenia in severe sepsis | <1,500/μL = abnormal |
| Urine culture + urinalysis | UTI / late-onset sepsis | Any growth in catheter specimen |
| Lumbar puncture (CSF) | Meningitis | WBC, protein, glucose, culture, Gram stain |
| Chest X-ray (CXR) | Pneumonia, RDS | Infiltrates, effusions |
| Tracheal aspirate culture | If intubated | Any growth of pathogen |
| Parameter | Term (<7 days) | Preterm (<7 days) |
|---|---|---|
| WBC | 0-30 cells/mm³ (mean 5) | 0-30 cells/mm³ (mean 9) |
| Protein | 0.3-2.5 g/L | 0.5-2.9 g/L |
| Glucose | 1.5-5.5 mmol/L | 1.5-5.5 mmol/L |
| CSF:blood glucose ratio | >0.6 | >0.6 |
| Test | Purpose | Normal Range (Neonate) |
|---|---|---|
| Serum glucose | Hypoglycemia (most common neonatal emergency) | 45-120 mg/dL |
| Sodium (Na) | Hypo/hypernatremia | 133-146 mEq/L |
| Potassium (K) | Hypo/hyperkalemia | 4.6-6.7 mEq/L (day 1-7) |
| Chloride (Cl) | Acid-base, electrolyte | 100-117 mEq/L |
| Calcium (Ca total) | Hypocalcemia - common preterm | 2.3-2.9 mmol/L (1.5-2.9) |
| Ionized calcium (iCa) | More accurate in sick neonates | 1.04-1.52 mmol/L (day 5) |
| Magnesium (Mg) | Hypomagnesemia - causes seizures | 0.62-1.02 mmol/L |
| Phosphate (PO4) | Metabolic bone disease in preterm | 1.7-3.5 mmol/L |
| Bicarbonate / CO2 | Metabolic acidosis/alkalosis | 18-25 mEq/L |
| BUN / Blood Urea | Renal function, hydration | 10-50 mg/dL (neonatal) |
| Serum Creatinine | Renal function (should fall after birth) | 0.4-1.0 mg/dL (day 1-5) |
| Uric acid | Metabolic disorders, renal | - |
| Parameter | Normal Neonate | Significance |
|---|---|---|
| pH | 7.35-7.45 | Acidosis in sepsis, metabolic disease, respiratory failure |
| PaCO2 | 35-45 mmHg | Respiratory failure, hyperventilation |
| PaO2 | 50-80 mmHg | Oxygenation |
| HCO3 | 18-25 mEq/L | Metabolic component |
| BE (Base Excess) | -4 to +4 | <-8 = significant acidosis |
| Lactate | <2.0 mmol/L | Elevated = poor perfusion, metabolic disease, sepsis |
| Test | Purpose | Normal |
|---|---|---|
| Total Bilirubin | Jaundice assessment (phototherapy threshold) | Varies by age/GA - see nomogram |
| Direct/Conjugated Bilirubin | Cholestasis, TORCH infections | <1.5 mg/dL (should be <20% of total) |
| AST / ALT | Hepatocellular damage (asphyxia, viral) | AST <80 U/L |
| Alkaline Phosphatase (ALP) | Metabolic bone disease, cholestasis | Higher in neonates (up to 400 U/L) |
| GGT | Cholestasis | <200 U/L in neonates |
| Albumin | Nutrition, hepatic synthetic function | 2.5-4.0 g/dL |
| Test | Purpose | Normal |
|---|---|---|
| Prothrombin Time (PT) | Clotting, hepatic synthesis, DIC, Vit K deficiency | 13-20 seconds (newborn) |
| aPTT | Clotting pathway, DIC | 30-55 seconds |
| INR | Standardized PT | <1.5 |
| Fibrinogen | DIC marker | 1.5-3.7 g/L |
| D-dimer | DIC (elevated) | <0.5 μg/mL |
| Platelet count | Thrombocytopenia | >150,000/μL |
| Test | Purpose | Normal Neonatal Values |
|---|---|---|
| Hemoglobin (Hb) | Anemia, polycythemia | Term: 16-22 g/dL; Preterm 34wk: ~15 g/dL |
| Hematocrit (Hct) | Polycythemia (>65% = significant) | Term: 50-65%; Preterm: 45-55% |
| Reticulocyte count | Hemolytic anemia (elevated), bone marrow failure | 3-7% (day 1-2) |
| Peripheral blood smear | Cell morphology - spherocytes (ABO), sickle cells, schistocytes (DIC) | Normal morphology |
| Blood group + Direct Coombs | Isoimmune hemolytic anemia (ABO, Rh) | Negative |
| Test | Purpose |
|---|---|
| Chest X-Ray (CXR) | RDS (ground-glass), pneumothorax, pneumonia, cardiomegaly |
| Echocardiography | Congenital heart disease, PDA, PPHN, cardiac function |
| Pulse oximetry (pre and post-ductal) | Pre-ductal (right hand) vs post-ductal (foot); difference >3% = PPHN or ductal shunting |
| ECG | Arrhythmias, electrolyte effects |
| Hyperoxia test | PaO2 <100 mmHg on 100% O2 = congenital cyanotic heart disease |
| Test | Purpose | When |
|---|---|---|
| Cranial Ultrasound (HUS) | IVH, periventricular leukomalacia (PVL), hydrocephalus | All <32 weeks by day 3-5; all at-risk neonates |
| EEG / aEEG (amplitude-integrated) | Seizure detection, HIE prognostication | Seizures, encephalopathy |
| MRI Brain | HIE injury pattern, IVH extent, PVL | After stabilization; best at 5-7 days for HIE |
| TORCH Screen | Congenital infections (Toxoplasma, Rubella, CMV, HSV) | Microcephaly, hepatosplenomegaly, thrombocytopenia, calcifications |
| Serum glucose, Ca, Mg, Na | Treatable causes of seizures | Any neonatal seizure |
| Lumbar puncture | Meningitis, SAH | Suspected meningitis |
| Test | Significance | Disorders Detected |
|---|---|---|
| Blood glucose | Hypoglycemia | Fatty acid oxidation defects, GSD, hyperinsulinism |
| Plasma ammonia | Hyperammonemia | Urea cycle defects, organic acidemias |
| Serum lactate (arterial) | Lactic acidosis | MSUD, MMA, PA, respiratory chain defects |
| Pyruvate | Lactate:pyruvate ratio | Pyruvate carboxylase deficiency |
| Blood gas + anion gap | Metabolic acidosis with high AG | Organic acidemias |
| Serum electrolytes | Anion gap = Na - (Cl + HCO3); normal <12 mmol | High AG = organic acids |
| Urine ketones | Ketonuria in neonate = abnormal (suggests IEM) | Organic acidemias |
| Urine reducing substances | Galactosemia, fructosemia, tyrosinemia | Clinitest positive |
| Urine ferric chloride test | MSUD, PKU | Green color = positive |
CRITICAL: Ammonia, lactate, and pyruvate must be collected WITHOUT a tourniquet, kept on ice, and analyzed within 15 minutes to prevent artifactual elevation.
| Test | Disorders Identified |
|---|---|
| Plasma amino acids (quantitative) | PKU, MSUD, urea cycle defects, organic acidemias, homocystinuria |
| Urine organic acids | Propionic acidemia (PA), methylmalonic acidemia (MMA), isovaleric acidemia (IVA), MSUD |
| Plasma acylcarnitine profile | Fatty acid oxidation defects (MCAD, LCHAD, VLCAD), organic acidemias |
| Total and free carnitine | Carnitine deficiency, organic acidemias |
| Urine amino acids | Amino acid transport disorders |
| Urine mucopolysaccharides | MPS disorders (Hurler, Hunter) |
| Urine oligosaccharides | Glycoprotein disorders |
| Plasma very long chain fatty acids (VLCFA) | Peroxisomal disorders (Zellweger) |
| Biotinidase activity | Biotinidase deficiency (treatable) |
| Thyroid function (TSH, T4) | Congenital hypothyroidism |
| Test | Disorders |
|---|---|
| CSF amino acids, neurotransmitters | GLUT-1 deficiency, neurotransmitter disorders |
| CSF lactate | Mitochondrial disorders |
| Urine purines/pyrimidines | Purine metabolism disorders |
| Enzyme assays (leukocytes/fibroblasts) | Lysosomal storage diseases |
| Molecular genetics (gene panel/WES/WGS) | Definitive diagnosis of any IEM |
| Skin/muscle biopsy | Mitochondrial disorders, storage diseases |
| Finding | Consider |
|---|---|
| High ammonia + respiratory alkalosis | Urea cycle defects (OTC, CPS deficiency) |
| High ammonia + metabolic acidosis + ketonuria | Organic acidemias (PA, MMA, IVA) |
| High lactate + high pyruvate | PDH deficiency, Pyruvate carboxylase deficiency |
| High lactate + normal pyruvate (ratio >25) | Respiratory chain (mitochondrial) disorder |
| Maple syrup odor + high leucine | MSUD (Maple Syrup Urine Disease) |
| Hypoglycemia + no ketones | Fatty acid oxidation defect (MCAD) |
| Hypoglycemia + hyperinsulinism | Congenital hyperinsulinism |
| Galactosuria + jaundice + E. coli sepsis | Galactosemia (classic) |
| Mousy odor + hyperphenylalaninemia | PKU |
| Non-immune hydrops + organomegaly | Lysosomal storage disease |
| Test | Initial | When Stable |
|---|---|---|
| Electrolytes (Na, K, Cl, HCO3) | Daily | 2-3x/week |
| Blood glucose | Every 6-24 hours | Daily |
| BUN / Creatinine | Daily | 2-3x/week |
| Calcium, Phosphate, Magnesium | Daily | 2-3x/week |
| Liver function (ALT, ALP, bilirubin) | Weekly | Weekly |
| Triglycerides | If on lipids | 2x/week |
| Albumin / Pre-albumin | Weekly | Weekly |
| Complete blood count | Weekly | Weekly |
| Category | Key Tests |
|---|---|
| Infection | Blood culture, CBC+diff, CRP, PCT, LP (CSF), urine culture, CXR |
| Metabolic - Basic | Glucose, Na, K, Ca, Mg, PO4, BUN, creatinine, LFTs, bilirubin |
| Blood gas | pH, pCO2, pO2, HCO3, lactate, BE |
| Hematology | Hb, Hct, platelets, reticulocytes, Coombs, peripheral smear |
| Coagulation | PT, aPTT, fibrinogen, D-dimer |
| Neurology | Cranial US, EEG/aEEG, MRI, TORCH, glucose/Ca/Mg/Na |
| Respiratory/Cardiac | CXR, Echo, pre/post-ductal SpO2, ECG |
| IEM Screen (Tier 1) | Glucose, ammonia, lactate, pyruvate, blood gas+AG, urine ketones, reducing substances |
| IEM Screen (Tier 2) | Plasma amino acids, urine organic acids, acylcarnitine profile, carnitine |
| IEM Screen (Tier 3) | CSF studies, enzyme assays, molecular genetics |
| TPN Monitoring | Daily electrolytes, glucose, BUN/Cr; weekly LFTs, triglycerides |